Skip to content

Outcome of vaginal hysterectomy with Different methods of hydrodissection

A clinicosurgical outcome of vaginal hysterectomy with normal saline versus Diluted Adrenaline Hydrodissection -A Randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/11/047198
Enrollment
100
Registered
2022-11-10
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: Clinico-Surgical Outcome Of Vaginal Hysterectomy With Normal Saline Versus Diluted Adrenaline Hydrodissection for 1 year : To study the clinicosurgical outcome of normal saline v/s di

Sponsors

Rohilkhand medical College and hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All women < 60 years of age undergoing vaginal hysterectomy.

Exclusion criteria

Exclusion criteria: 1)Hemoglobin 2)Medical disorders â?? Hypertension Diabetes Ischemic heart disease Hepatic or renal disease COPD Migraine Epilepsy History of previous pelvic surgery Co-existing pelvic pathology or Enlarged uterus.( >12 weeks size

Design outcomes

Primary

MeasureTime frame
compare the effect of Normal saline versus Adrenaline on intra-operative blood loss by submucosal infiltration during vaginal hysterectomy. To compare the operating time and ease of dissection from vaginal incision till creation of flaps. 3)To compare post operative outcome.Timepoint: 1 year

Secondary

MeasureTime frame
1)To compare the operating time and ease of dissection from vaginal incision till creation of flaps. 2)To compare post operative outcome.Timepoint: 1 year

Countries

India

Contacts

Public ContactDr Rashee agarwal

Rohilkhand medical College and hospital

drrashmirprasad@gmail.com9321089998

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026